Items where authors include "Lambert, T."

Article

Boddy, S.L., Simpson, R.M. orcid.org/0000-0003-1677-5938, Walters, S.J. et al. (38 more authors) (2025) Further development of a patient-reported outcome measure to assess the impact of oral secretion problems in people living with MND. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. ISSN 2167-8421

Gould, R.L., McDermott, C.J., Thompson, B.J. orcid.org/0000-0002-5516-8797 et al. (29 more authors) (2024) Acceptance and Commitment Therapy plus usual care for improving quality of life in people with motor neuron disease (COMMEND): a multicentre, parallel, randomised controlled trial in the UK. The Lancet, 403 (10442). pp. 2381-2394. ISSN 0140-6736

Lombardo, F.L. orcid.org/0000-0001-6183-0735, Spila Alegiani, S., Mayer, F. et al. (93 more authors) (2023) A randomized double-blind clinical trial on safety and efficacy of tauroursodeoxycholic acid (TUDCA) as add-on treatment in patients affected by amyotrophic lateral sclerosis (ALS): the statistical analysis plan of TUDCA-ALS trial. Trials, 24 (1). 792. ISSN 1468-6708

Iorio, A., Barbara, A., Makris, M. orcid.org/0000-0001-7622-7939 et al. (21 more authors) (2017) Natural history and clinical characteristics of inhibitors in previously treated haemophilia A patients: A case series. Haemophilia, 23 (2). pp. 255-263. ISSN 1351-8216

Fischer, K., Iorio, A., Lassila, R. et al. (8 more authors) (2015) Inhibitor development in non-severe haemophilia across Europe. Thrombosis and Haemostasis, 114 (4). pp. 670-675. ISSN 0340-6245

Fischer, K., Lassila, R., Peyvandi, F. et al. (8 more authors) (2015) Inhibitor development in haemophilia according to concentrate Four-year results from the European HAemophilia Safety Surveillance (EUHASS) project. THROMBOSIS AND HAEMOSTASIS, 113 (5). pp. 968-975. ISSN 0340-6245